{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Déontologie médicale : Questions médicales les plus fréquentes",
"headline": "Déontologie médicale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Déontologie médicale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-04",
"dateModified": "2025-02-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Déontologie médicale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Éthique clinique",
"url": "https://questionsmedicales.fr/mesh/D026690",
"about": {
"@type": "MedicalCondition",
"name": "Éthique clinique",
"code": {
"@type": "MedicalCode",
"code": "D026690",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N05.350.340.162"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Serment d'Hippocrate",
"alternateName": "Hippocratic Oath",
"url": "https://questionsmedicales.fr/mesh/D006625",
"about": {
"@type": "MedicalCondition",
"name": "Serment d'Hippocrate",
"code": {
"@type": "MedicalCode",
"code": "D006625",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N05.350.340.162.500.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Déontologie médicale",
"alternateName": "Ethics, Medical",
"code": {
"@type": "MedicalCode",
"code": "D004992",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Alistair Wardrope",
"url": "https://questionsmedicales.fr/author/Alistair%20Wardrope",
"affiliation": {
"@type": "Organization",
"name": "Academic Neurology Unit, The University of Sheffield, Sheffield, UK ajwardrope1@sheffield.ac.uk."
}
},
{
"@type": "Person",
"name": "David Isaacs",
"url": "https://questionsmedicales.fr/author/David%20Isaacs",
"affiliation": {
"@type": "Organization",
"name": "Clinical Ethics Service, Sydney Children's Hospital Network, Children's Hospital at Westmead and Sydney Children's Hospital, Randwick, Australia; Sydney Health Ethics, 92/94 Parramatta Rd, Camperdown, NSW 2050, Australia. Electronic address: davidisaacs@health.nsw.gov.au."
}
},
{
"@type": "Person",
"name": "Anne Preisz",
"url": "https://questionsmedicales.fr/author/Anne%20Preisz",
"affiliation": {
"@type": "Organization",
"name": "Clinical Ethics Service, Sydney Children's Hospital Network, Children's Hospital at Westmead and Sydney Children's Hospital, Randwick, Australia; Sydney Health Ethics, 92/94 Parramatta Rd, Camperdown, NSW 2050, Australia."
}
},
{
"@type": "Person",
"name": "Stuart McLennan",
"url": "https://questionsmedicales.fr/author/Stuart%20McLennan",
"affiliation": {
"@type": "Organization",
"name": "Institute of History and Ethics in Medicine, Technical University of Munich, Ismaninger Straße 22, 81675, Munich, Germany. stuart.mclennan@tum.de."
}
},
{
"@type": "Person",
"name": "Amelia Fiske",
"url": "https://questionsmedicales.fr/author/Amelia%20Fiske",
"affiliation": {
"@type": "Organization",
"name": "Institute of History and Ethics in Medicine, Technical University of Munich, Ismaninger Straße 22, 81675, Munich, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A nomogram and risk classification system predicting esophageal stricture after endoscopic submucosal dissection of a large area for early esophageal cancer.",
"datePublished": "2022-12-19",
"url": "https://questionsmedicales.fr/article/36537007",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jso.27172"
}
},
{
"@type": "ScholarlyArticle",
"name": "Affordable Care Act Medicaid Expansion is Associated With Increased Utilization of Minimally Invasive Lung Resection for Early Stage Lung Cancer.",
"datePublished": "2022-11-07",
"url": "https://questionsmedicales.fr/article/36341749",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/00031348221138081"
}
},
{
"@type": "ScholarlyArticle",
"name": "Serum-derived piR-hsa-164586 of extracellular vesicles as a novel biomarker for early diagnosis of non-small cell lung cancer.",
"datePublished": "2022-09-28",
"url": "https://questionsmedicales.fr/article/36249068",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fonc.2022.850363"
}
},
{
"@type": "ScholarlyArticle",
"name": "The influence of body mass index on the tolerability and effectiveness of full-weight-based paclitaxel chemotherapy in women with early-stage breast cancer.",
"datePublished": "2022-08-16",
"url": "https://questionsmedicales.fr/article/35974240",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10549-022-06681-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Role of Surgical Axillary Staging Prior to Immediate Breast Reconstruction in the Era of De-Escalation of Axillary Management in Early Breast Cancer.",
"datePublished": "2022-08-04",
"url": "https://questionsmedicales.fr/article/36013232",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/jpm12081283"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Qualité, accès, évaluation des soins de santé",
"item": "https://questionsmedicales.fr/mesh/D017530"
},
{
"@type": "ListItem",
"position": 3,
"name": "Éthique",
"item": "https://questionsmedicales.fr/mesh/D004989"
},
{
"@type": "ListItem",
"position": 4,
"name": "Déontologie",
"item": "https://questionsmedicales.fr/mesh/D004995"
},
{
"@type": "ListItem",
"position": 5,
"name": "Éthique clinique",
"item": "https://questionsmedicales.fr/mesh/D026690"
},
{
"@type": "ListItem",
"position": 6,
"name": "Déontologie médicale",
"item": "https://questionsmedicales.fr/mesh/D004992"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Déontologie médicale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Déontologie médicale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Droits des patients",
"headline": "Droits des patients sur Déontologie médicale",
"description": "Quels sont les droits fondamentaux des patients ?\nComment les patients peuvent-ils exprimer leurs préoccupations ?\nQuelle est l'importance de l'information dans le consentement ?\nComment la déontologie aborde-t-elle la fin de vie ?\nQuelles sont les implications de la recherche sur les droits des patients ?",
"url": "https://questionsmedicales.fr/mesh/D004992?mesh_terms=Early+Detection+of+Cancer&page=1000#section-droits des patients"
},
{
"@type": "MedicalWebPage",
"name": "Principes éthiques",
"headline": "Principes éthiques sur Déontologie médicale",
"description": "Quels sont les principes fondamentaux de la déontologie médicale ?\nComment la déontologie protège-t-elle les patients ?\nQuel rôle joue le consentement éclairé ?\nQu'est-ce que la bienfaisance en médecine ?\nComment la déontologie aborde-t-elle les conflits d'intérêts ?",
"url": "https://questionsmedicales.fr/mesh/D004992?mesh_terms=Early+Detection+of+Cancer&page=1000#section-principes éthiques"
},
{
"@type": "MedicalWebPage",
"name": "Éthique de la recherche",
"headline": "Éthique de la recherche sur Déontologie médicale",
"description": "Quels sont les principes éthiques en recherche médicale ?\nComment garantir la sécurité des participants à la recherche ?\nQu'est-ce que le comité d'éthique ?\nPourquoi est-il important de publier les résultats de recherche ?\nComment gérer les conflits d'intérêts en recherche ?",
"url": "https://questionsmedicales.fr/mesh/D004992?mesh_terms=Early+Detection+of+Cancer&page=1000#section-éthique de la recherche"
},
{
"@type": "MedicalWebPage",
"name": "Responsabilités des médecins",
"headline": "Responsabilités des médecins sur Déontologie médicale",
"description": "Quelles sont les responsabilités d'un médecin envers ses patients ?\nComment un médecin doit-il gérer les erreurs médicales ?\nQuelle est l'importance de la formation continue ?\nComment un médecin doit-il traiter les patients vulnérables ?\nQuelles sont les implications de la télémédecine en déontologie ?",
"url": "https://questionsmedicales.fr/mesh/D004992?mesh_terms=Early+Detection+of+Cancer&page=1000#section-responsabilités des médecins"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Quels sont les droits fondamentaux des patients ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les droits incluent le droit à l'information, à la confidentialité et à un consentement éclairé."
}
},
{
"@type": "Question",
"name": "Comment les patients peuvent-ils exprimer leurs préoccupations ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent le faire par le biais de plaintes formelles, de discussions avec le médecin ou via des médiateurs."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'information dans le consentement ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'information permet aux patients de prendre des décisions éclairées concernant leur traitement."
}
},
{
"@type": "Question",
"name": "Comment la déontologie aborde-t-elle la fin de vie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle prône le respect des souhaits du patient, y compris les directives anticipées et les soins palliatifs."
}
},
{
"@type": "Question",
"name": "Quelles sont les implications de la recherche sur les droits des patients ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La recherche doit respecter les droits des participants, y compris le consentement et la confidentialité."
}
},
{
"@type": "Question",
"name": "Quels sont les principes fondamentaux de la déontologie médicale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principes incluent le respect de l'autonomie, la bienfaisance, la non-malfaisance et la justice."
}
},
{
"@type": "Question",
"name": "Comment la déontologie protège-t-elle les patients ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle garantit le respect des droits des patients et la confidentialité des informations médicales."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le consentement éclairé ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le consentement éclairé est essentiel pour respecter l'autonomie du patient avant tout traitement."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que la bienfaisance en médecine ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "La bienfaisance implique d'agir dans l'intérêt du patient et de promouvoir son bien-être."
}
},
{
"@type": "Question",
"name": "Comment la déontologie aborde-t-elle les conflits d'intérêts ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle exige la transparence et la divulgation des conflits d'intérêts pour protéger les patients."
}
},
{
"@type": "Question",
"name": "Quels sont les principes éthiques en recherche médicale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principes incluent le respect des personnes, la bienfaisance, la non-malfaisance et la justice."
}
},
{
"@type": "Question",
"name": "Comment garantir la sécurité des participants à la recherche ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est essentiel d'évaluer les risques, d'obtenir un consentement éclairé et de surveiller les effets."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que le comité d'éthique ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est un groupe qui évalue les protocoles de recherche pour s'assurer qu'ils respectent les normes éthiques."
}
},
{
"@type": "Question",
"name": "Pourquoi est-il important de publier les résultats de recherche ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "La publication favorise la transparence, le partage des connaissances et l'amélioration des pratiques médicales."
}
},
{
"@type": "Question",
"name": "Comment gérer les conflits d'intérêts en recherche ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est crucial de déclarer tout conflit d'intérêts et de s'assurer qu'il n'influence pas les résultats."
}
},
{
"@type": "Question",
"name": "Quelles sont les responsabilités d'un médecin envers ses patients ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un médecin doit fournir des soins compétents, respecter la dignité et informer le patient."
}
},
{
"@type": "Question",
"name": "Comment un médecin doit-il gérer les erreurs médicales ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il doit les reconnaître, en informer le patient et prendre des mesures pour éviter leur répétition."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de la formation continue ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La formation continue est essentielle pour maintenir des compétences à jour et garantir des soins de qualité."
}
},
{
"@type": "Question",
"name": "Comment un médecin doit-il traiter les patients vulnérables ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il doit faire preuve de sensibilité, respecter leur dignité et adapter les soins à leurs besoins."
}
},
{
"@type": "Question",
"name": "Quelles sont les implications de la télémédecine en déontologie ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La télémédecine doit respecter les mêmes principes éthiques, notamment la confidentialité et le consentement."
}
}
]
}
]
}
Esophageal stricture is a troublesome adverse effect of endoscopic submucosal dissection (ESD) for early esophageal cancer. However, risk factors of post-ESD esophageal stricture formation are incompr...
Patients who underwent ESD for early esophageal cancer between 2014 and 2021 at the Beijing Friendship Hospital, Capital Medical University, were recruited. A nomogram and risk classification system w...
Stricture formed in 36 patients, while stricture was not observed in the remaining 112 patients. Operative time (odds ratio [OR]: 1.01; 95% confidence interval [CI]: 1.00-1.01; p < 0.01); lesions >3/4...
We developed a nomogram and risk stratification system to predict post-ESD esophageal stricture using three independent risk factors....
Minimally invasive lung resection (MILR) is underutilized in the United States. Under the Affordable Care Act (ACA), 39 states adopted Medicaid expansion, while 12 did not. Although Medicaid expansion...
The National Cancer Database was queried for adult patients from 2010 to 2018 with cT1/2N0M0 non-small cell lung cancer who received surgical resection by wedge, segmentectomy, or lobectomy. Patients ...
There were 41,439 patients who met inclusion criteria: 20,446 (49.3%) in expansion states and 20,993 (50.7%) in non-expansion states. Multivariable DID analysis showed that Medicaid expansion was asso...
Although Medicaid expansion was associated with increased utilization of MILR for early stage lung cancer, the treatment effect was modest. This suggests that barriers in access to MILR are larger tha...
Non-small cell lung cancer (NSCLC) is a major cause of death in those with malignant tumors. To achieve the early diagnosis of NSCLC, we investigated serum-derived Piwi-interacting RNA (piRNA) of extr...
To investigate the influence of body mass index (BMI) on the tolerability and effectiveness of full-weight-based paclitaxel chemotherapy in early breast cancer patients....
Early-stage breast cancer patients who received (neo)adjuvant weekly paclitaxel 80 mg/m...
Four hundred (400) patients were included in this study; 200 (50%) lean, 125 (31%) overweight, and 75 (19%) obese patients. The adjusted odds ratio to receive RDI < 85% for BMI was 1.02 (p value, .263...
BMI did not significantly influence the tolerability and effectiveness of full-weight-based paclitaxel chemotherapy. Therefore, the results of this study align with current guideline recommendations o...
Postmastectomy radiotherapy (PMRT) following immediate breast reconstruction (IBR) is associated with postoperative complications. Although the incidence of node-positive breast cancer is declining, a...
During RT cycles, the tumor response pattern could affect tumor coverage and may lead to organs at risk of overdose. As such, early prediction of significant volumetric changes could therefore reduce ...
CBCT images from 40 HN cancer patients were collected weekly during RT treatment. From the obtained images, the Clinical Target Volume (CTV) and Parotid Glands (PG) regions of interest were utilized t...
The proposed framework was able to achieve 0.90 classification performance accuracy while detecting a small subset of discriminative characteristics from the 1st week of RT. The selected features were...
The use of machine learning algorithms offers promising perspectives for fast and reliable early prediction of large volumetric deviations as a result of RT treatment, exploiting hidden patterns in th...
The value of the lymphocyte-to-C-reactive protein (CRP) ratio (LCR) in early breast cancer (BC) is unclear. We explored the correlation between the LCR and survival of patients with early BC and estab...
In this retrospective study, we randomized 623 patients with early-stage BC diagnosed in December 2010 to October 2012 at the Sun Yat-sen University Cancer Center to training and verification datasets...
The LCR, lymphatic vessel invasion (LVI), progesterone receptor (PR) status, and Ki67 index were independent prognostic factors of OS. And the LCR and LVI are associated to DFS too. High LCR was assoc...
The LCR was a significant prognostic predictor of OS and DFS in early BC. The LCR-based prognostic signatures could be a useful tool for individualized therapeutic guidance....
Quantitative depth estimation of tumor invasion in early gastric cancer by scattering of circularly polarized light is computationally investigated using the Monte Carlo method. Using the optical para...
Metabolic reprogramming is now characterized as one of the core hallmarks of cancer, and it has already been shown that the altered genomic profile of metabolically rewired cancer cells can give valua...
We first developed and analytically validated highly sensitive RT-qPCR assays for the quantification of...
An overexpression of MRGs was observed at a high frequency in the CTCs isolated from early NSCLC patients, thereby supporting the role of MRGs in metastatic processes. The glycolytic and mesenchymal s...
Individuals with prolonged or frequent episodes account for a disproportionate share of the burden of depression. However, there are surprisingly few data on whether individuals at risk for developing...